Jury Awarded $15.1 Million After Hospital Negligence
A New Haven jury found Yale New Haven Hospital liable for permanent eye damage during a 2019 brain surgery.
Updated on Sept. 29, 2026 in Stroke
A jury has awarded $15.1 million to 85-year-old Lioudmila Pyleva after determining that Yale New Haven Hospital was negligent during her 2019 brain surgery. The verdict concludes a legal case centered on an error where toxic antiseptic solutions dripped into the patient's eye.
Why it matters
The case highlights critical patient safety concerns regarding the handling of surgical chemicals during neurosurgical procedures. It establishes legal accountability for complications arising from the improper application of antiseptic solutions in a hospital environment.
The jury found that nearly 90% of Lioudmila Pyleva's corneal surface was destroyed after exposure to Hibiclens and ChloraPrep. Pyleva was 78 at the time of surgery and was already blind in her left eye, resulting in total vision loss.
The players
Lioudmila Pyleva
She is an 85-year-old patient and Groton resident who suffered permanent vision loss during a 2019 brain surgery.
Yale New Haven Hospital
It is a major teaching hospital in New Haven that was found liable for surgical negligence in this case.
Dr. Jennifer Moliterno
She is the neurosurgeon who handled the antiseptic chemicals during the patient's brain surgery.
The details
During the procedure, neurosurgeon Dr. Jennifer Moliterno handled toxic antiseptic chemicals that dripped into and remained in Pyleva's eye. The jury determined that this handling was negligent, leading to the permanent destruction of the eye's corneal surface.
Timeline
The toxic nature of the solutions to the eye became known in the 1980s.
Lioudmila Pyleva underwent brain surgery on April 2, 2019.
The jury reached their verdict in September 2026.
Health Landscape
This verdict aligns with decades of medical literature established since the 1980s identifying the risks of applying certain antiseptics near ocular tissue. The case underscores how established safety knowledge must be strictly applied in high-stakes neurosurgical settings.
This case highlights the importance of patients discussing surgical safety and sterilization protocols with their medical providers before procedures. It serves as a reminder for patients to understand potential risks involving chemicals used near sensitive sensory organs during surgery.
The takeaway
Patients should feel empowered to ask surgeons about the specific materials and safety measures used during their operations. Vigilance regarding the risks of chemical exposure during surgery remains a vital part of protecting patient health during hospital stays.
Further reading
For additional context on neurological procedures and risks, visit the New Haven Stroke section.
